Breakthrough Antibody Treatment Shows Promise in Fighting Triple-Negative Breast Cancer
In a groundbreaking discovery, Israeli researchers at the Weizmann Institute of Science (WIS) and their US colleagues have developed an antibody-based treatment that harnesses the body’s own immune system to effectively target and destroy cancer cells. This innovative approach, detailed in a recent statement by WIS, holds significant potential for combating triple-negative breast cancer, a particularly aggressive form of the disease.
Unveiling the Immune Suppression Mechanism
Triple-negative breast cancer, characterized by the absence of three key hormone receptors (estrogen receptor, progesterone receptor, and HER2), often exhibits resistance to conventional therapies. WIS scientists revealed that this type of cancer creates a unique immunosuppressive environment. The cancer cells, while expressing low levels of the protein CD84, induce nearby immune cells to produce copious amounts of CD84. These immune cells then form “molecular bridges” that effectively prevent other immune cells from attacking the tumor, hindering the body’s natural defenses.
Antibody Treatment Revives Immune Response
The research team developed an antibody treatment specifically designed to block the formation of these CD84-mediated “bridges.” In a series of experiments using mouse models, the antibody treatment successfully restored the immune system’s ability to mount effective attacks against cancer cells. This resulted in significantly slowed tumor growth and, in some cases, complete tumor regression.
Importantly, the antibody demonstrates selectivity, targeting cells with elevated CD84 levels, leaving healthy immune cells largely unharmed. Studies with genetically engineered mice lacking CD84 further confirmed the detrimental role of CD84 in tumor growth and the positive impact of its suppression.
Broader Cancer Therapies on the Horizon
The researchers suggest that this novel antibody treatment strategy could potentially be applied to a variety of cancer types. By focusing on manipulating the tumor microenvironment rather than the cancer cells themselves, this approach offers a promising avenue for developing more effective and targeted cancer therapies.
Want to learn more about this groundbreaking research and the future of cancer treatment? Visit the Weizmann Institute of Science website for more details.